Engineering an in vitro air-blood barrier by 3D bioprinting
By Lenke Horváth, Y. Umehara, Corinne Jud, F. Blank, A. Petri‐Fink, B. Rothen‐Rutishauser. Scientific Reports, 2015
300 citations recorded by the source corpus.
Intensive efforts in recent years to develop and commercialize in vitro alternatives in the field of risk assessment have yielded new promising two- and three dimensional (3D) cell culture models. Nevertheless, a realistic 3D in vitro alveolar model is not available yet. Here we report on the biofabrication of the human air-blood tissue barrier analogue composed of an endothelial cell, basement membrane and epithelial cell layer by using a bioprinting technology. In contrary to the manual method, we demonstrate that this technique enables automatized and reproducible creation of thinner and more homogeneous cell layers, which is required for an optimal air-blood tissue barrier. This bioprinting platform will offer an excellent tool to engineer an advanced 3D lung model for high-throughput screening for safety assessment and drug efficacy testing.
Subfields: Biomedical Engineering, Oncology
View Paper: https://www.semanticscholar.org/paper/0a0232027a4572050cbd51c0683ac24ac7134ba7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
In Oncology
Citations in the corpus
- Current advances and future perspectives in extrusion-based bioprinting. (2016, background): “demonstrated bioprinting of lung tissue analogues for the first time [23].”
- Aging and aging-related diseases: from molecular mechanisms to interventions and treatments (2022, background): “Thus far, some research teams have tried to implant functional lung tissue formed by lung stem cells to improve gas exchange capacity in COPD, but they have not achieved the desired effect.(629) Antioxidant therapy is also a current strategy to combat the aging process and may protect against COPD.”
- A comprehensive review on droplet-based bioprinting: Past, present and future. (2016, background): “While DBB has a process resolution higher than that of extrusion-based bioprinting and possesses a greater versatility in incorporating multiple biologics, DBB has attracted several researchers in the bioprinting community as well as researchers adopting bioprinting technology in other field of stud”